Login / Signup

Successful treatment with sorafenib for sunitinib-refractory metastatic papillary renal cell carcinoma: Potential impact of Raf overexpression on predicting the efficacy of sorafenib.

Ryota MorinagaTakashi KawaharaJun-Ichi TeranishiMakoto ChumaKoji IzumiYasuhide MiyoshiMasahiro YaoMasako OtaniHiroshi MiyamotoHiroji Uemura
Published in: IJU case reports (2018)
As sorafenib blocks Raf signaling, the expression of Raf may serve as a useful predictor of the efficacy of sorafenib.
Keyphrases
  • renal cell carcinoma
  • poor prognosis
  • small cell lung cancer
  • squamous cell carcinoma
  • cell proliferation
  • transcription factor
  • binding protein
  • climate change
  • long non coding rna